2018
DOI: 10.1016/j.ijantimicag.2018.03.005
|View full text |Cite
|
Sign up to set email alerts
|

Corrigendum to ‘Panton-Valentine Leucocidin (PVL) Staphylococcus aureus a position statement from the International Society of Chemotherapy’ [International Journal of Antimicrobial Agents 51/1 (2018) 16-25]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

2019
2019
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 78 publications
(115 reference statements)
0
2
0
1
Order By: Relevance
“…The main protease (Mpro) enzyme of SARS-CoV-2 is the one that helps in the conversion of its polypeptides into functional proteins and is responsible for its transcription and replication as well [ 18 ]. Accordingly, targeting the Mpro of SARS-CoV-2 appears to be very promising for the management of the COVID-19 pandemic [ 19 ].…”
Section: Introductionmentioning
confidence: 99%
“…The main protease (Mpro) enzyme of SARS-CoV-2 is the one that helps in the conversion of its polypeptides into functional proteins and is responsible for its transcription and replication as well [ 18 ]. Accordingly, targeting the Mpro of SARS-CoV-2 appears to be very promising for the management of the COVID-19 pandemic [ 19 ].…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, associations between phage activity and pathogenicity have been observed [8]. Numerous S. aureus prophages have been identified to date and analysis of their sequences has found genes encoding for Panton-Valentine leukocidin (PVL), exfoliative toxin A (eta), and the immune evasion cluster (IEC), which includes the enterotoxin S (sea), staphylokinase (sak), the chemotaxis inhibitory protein (chp), and the staphylococcal complement inhibitor (scn) [9][10][11][12][13][14]. This is in addition to several other virulence factors and genes conferring antibiotic resistance.…”
Section: Introductionmentioning
confidence: 99%
“…Therapeutisch eignen sich bei PVLP-SA-Infektion v. a. Clindamycin und Linezolid, da sie als Proteinsyntheseinhibito-ren auch die PVL-Produktion potenziell hemmen können. Die Gabe von β-Laktam-Antibiotika sollte hochdosiert und antibiogrammgerecht erfolgen [5]. Nach PLVPSA-Nachweis wurde auch in diesem Fall die Therapie mit Linezolid und Ceftriaxon begonnen.…”
Section: Befunde Und Erste Diagnostikunclassified